ENTITY
Brii Biosciences

Brii Biosciences (2137 HK)

35
Analysis
Health CareChina
Brii Biosciences operates as a biotechnology company. The Company discovers and develops therapeutics and medicines for the treatment of diseases. Brii Biosciences serves customers in the United States and China.
more
Refresh
24 Jan 2024 11:32

More Hong Kong Stocks Priced For Liquidation

This note looks at Net Nets, (current assets less current liabilities), then subtract debt not included in current liabilities. Benjamin Graham...

Logo
590 Views
Share
04 Apr 2024 12:45

Hong Kong Connect Flows (Mar): 12 Month High of $9.8bn Inflows

We analyzed the Hong Kong Connect Scheme for March and highlight flows for Bank of China, Tencent, China Mobile, CNOOC, ZTO, Anta.

Logo
282 Views
Share
25 Feb 2024 05:50

Index Rebalance & ETF Flow Recap: HSCEI, HSCI, HSTECH, HSIII, STTF, Top50, Div+, FXI, FnGuide

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
564 Views
Share
bullishUBTech Robotics
18 Feb 2024 11:00

HSCI Index Rebalance: 25 Adds, 29 Deletes & Changes to Southbound Stock Connect

There are 25 adds and 29 deletes for the HSCI in March. 21 stocks will be added to Stock Connect while 27 will be deleted. Positions via the...

Logo
645 Views
Share
bullishShriram Finance
07 Jan 2024 05:10

Index Rebalance & ETF Flow Recap: HSCEI, HSCI, KRX New Deal, NIFTY50, NEXT50, CNXBANK

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
758 Views
Share
x